Rheumocam

1 x 100 ml

Oral Suspension

Active substance

Meloxicam : 15 mg/ml

ATC code

QM01AC06 Meloxicam

QM01AC Oxicams

QM01A Antiinflammatory and antirheumatic products, non-steroids (NSAIDs)

QM01 Antiinflammatory and antirheumatic products

QM Musculo-skeletal system

Species

Horses.

Indications

Alleviation of inflammation and pain in both acute and chronic musculo-skeletal disorders in horses.

Dose to be administered and administration route

To be administered either mixed with food or directly into the mouth at a dosage of 0.6 mg/kg body weight, once daily, up to 14 days. In case the veterinary medicinal product is mixed with food, it should be added to a small quantity of food, prior to feeding.

The suspension should be given using the Rheumocam measuring syringe provided in the package. The syringe fits onto the bottle and has a 2 ml scale.

Shake well before use.

To ensure a correct dosage, body weight should be determined as accurately as possible. The use of suitably calibrated measuring equipment is recommended.

Avoid introduction of contamination during use.

Adverse reactions

Horses:

Very rare

(<1 animal / 10,000 animals treated, including isolated reports):

Appetite loss, Lethargy

Diarrhoea¹, Abdominal pain, colitis

Urticaria^1,2, Anaphylactoid reaction³

¹Reversible

²Slight

³May be serious (including fatal). If such a reaction occurs, it should be treated symptomatically.

If adverse reactions occur, treatment should be discontinued and the advice of a veterinarian should be sought.

Reporting adverse events is important. It allows continuous safety monitoring of a veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to either the marketing authorisation holder or its local representative or the national competent authority via the national reporting system. See also the package leaflet for respective contact details.